Zentalis Pharmaceuticals (NASDAQ:ZNTL) Releases Earnings Results, Misses Expectations By $0 82 EPS kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) has received an average recommendation of “Buy” from the six research firms that are covering the firm, MarketBeat reports. Six research analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have issued ratings on the stock in the last […]
Zentalis Pharmaceuticals (NASDAQ:ZNTL – Get Rating) had its price target hoisted by Stifel Nicolaus from $45.00 to $50.00 in a research report sent to investors on Wednesday, The Fly reports. Other equities analysts also recently issued research reports about the stock. Wedbush raised their target price on shares of Zentalis Pharmaceuticals from $31.00 to $38.00 […]
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) – Investment analysts at HC Wainwright decreased their Q2 2023 earnings per share estimates for shares of Zentalis Pharmaceuticals in a research note issued to investors on Thursday, May 11th. HC Wainwright analyst A. Fein now expects that the company will earn ($1.15) per share for the quarter, […]
Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) shot up 7.3% on Thursday . The stock traded as high as $18.95 and last traded at $18.77. 313,732 shares traded hands during trading, a decline of 44% from the average session volume of 555,929 shares. The stock had previously closed at $17.50. Analyst Upgrades and […]